NASDAQ:IRIX IRIDEX (IRIX) Stock Price, News & Analysis $0.67 +0.02 (+2.81%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.66 -0.01 (-2.09%) As of 09/18/2026 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About IRIDEX Stock (NASDAQ:IRIX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IRIDEX alerts:Sign Up Key Stats Today's Range$0.64▼$0.6750-Day Range$0.61▼$1.0752-Week Range$0.61▼$1.65Volume75,438 shsAverage Volume74,421 shsMarket Capitalization$11.77 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingHold Company Overview IRIDEX Corporation develops and markets ophthalmic laser systems and related delivery devices used by eye-care professionals. Its technologies are designed primarily to treat glaucoma and retinal diseases, including conditions that can lead to vision loss. The company’s product portfolio includes laser systems, probes and treatment delivery devices that support procedures such as MicroPulse cyclophotocoagulation and retinal photocoagulation. Its Cyclo G6 platform is used in glaucoma treatments, while its retinal laser products are intended for procedures involving diseases of the retina. Founded in 1989 and headquartered in Mountain View, California, IRIDEX serves ophthalmologists, hospitals, ambulatory surgery centers and other eye-care providers. The company markets its products in the United States and internationally through direct sales and distribution relationships.AI Generated. May Contain Errors. Read More IRIDEX Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreIRIX MarketRank™: IRIDEX scored higher than 33% of companies evaluated by MarketBeat, and ranked 722nd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingIRIDEX has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialIRIDEX has a consensus price target of $3.00, representing about 347.8% upside from its current price of $0.67.Amount of Analyst CoverageIRIDEX has only been the subject of 1 research reports in the past 90 days.Read more about IRIDEX's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IRIDEX is -3.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IRIDEX is -3.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about IRIDEX's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.92% of the float of IRIDEX has been sold short.Short Interest Ratio / Days to CoverIRIDEX has a short interest ratio ("days to cover") of 0.98, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IRIDEX has recently increased by 291.80%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIRIDEX does not currently pay a dividend.Dividend GrowthIRIDEX does not have a long track record of dividend growth. News and Social Media1.4 / 5News SentimentN/A News SentimentIRIDEX has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IRIDEX insiders have not sold or bought any company stock.Percentage Held by Insiders8.60% of the stock of IRIDEX is held by insiders.Percentage Held by Institutions20.10% of the stock of IRIDEX is held by institutions.Read more about IRIDEX's insider trading history. Receive IRIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRIX Stock News HeadlinesIridex: Q2 Earnings SnapshotAugust 18, 2026 | chron.comIridex reaffirms 2026 revenue guidance of $51m-$53m while highlighting working-capital build tied to headquarters relocationAugust 18, 2026 | seekingalpha.comThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.September 20 at 1:00 AM | Traders Agency (Ad)IRIDEX Corporation (IRIX) Q2 2026 Earnings Call TranscriptAugust 18, 2026 | seekingalpha.comIridex Reports Second Quarter 2026 Financial ResultsAugust 18, 2026 | globenewswire.comIridex to Report Second Quarter 2026 Financial Results on August 18, 2026August 4, 2026 | globenewswire.comIridex Adds EndoProbe® Handpieces to EyeProGPO Product OfferingJuly 20, 2026 | globenewswire.comIridex to Present at the Planet MicroCap Las Vegas 2026 ConferenceJune 9, 2026 | globenewswire.comSee More Headlines IRIX Stock Analysis - Frequently Asked Questions How have IRIX shares performed this year? IRIDEX's stock was trading at $1.14 at the beginning of 2026. Since then, IRIX stock has decreased by 41.2% and is now trading at $0.67. How were IRIDEX's earnings last quarter? IRIDEX Corporation (NASDAQ:IRIX) posted its quarterly earnings results on Tuesday, August, 18th. The medical equipment provider reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.06. The medical equipment provider earned $12.57 million during the quarter, compared to analyst estimates of $13.59 million. Read the conference call transcript. Who are IRIDEX's major shareholders? IRIDEX's top institutional shareholders include Weber Capital Management LLC ADV (1.04%), United Capital Financial Advisors LLC (0.20%), Diversify Advisory Services LLC (0.19%) and Bank of New York Mellon Corp (0.15%). Insiders that own company stock include Patrick Mercer, William M Moore, Beverly A Huss and Romeo R Dizon. View institutional ownership trends. How do I buy shares of IRIDEX? Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IRIDEX own? Based on aggregate information from My MarketBeat watchlists, some other companies that IRIDEX investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET) and CrowdStrike (CRWD). Company Calendar Last Earnings8/18/2026Today9/20/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 IRIX's financial health is in the Red zone, according to TradeSmith. IRIX has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:IRIX CIK1006045 Webwww.iridex.com Phone(650) 940-4700Fax650-940-4710Employees108Year Founded1989Price Target and Rating Average Price Target for IRIDEX$3.00 High Price Target$3.00 Low Price Target$3.00 Potential Upside/Downside+347.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4.44 million Net Margins-6.88% Pretax Margin-6.58% Return on EquityN/A Return on Assets-12.55% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.08 Sales & Book Value Annual Sales$52.67 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value($0.06) per share Price / Book-11.17Miscellaneous Outstanding Shares17,570,000Free Float16,054,000Market Cap$11.77 million OptionableOptionable Beta0.62 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:IRIX) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredIran War: Why Is Trump Protecting THEM?A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...Banyan Hill Publishing | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technolog...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
